Patent application number | Description | Published |
20090006603 | Methods for Operating Virtual Networks, Data Network System, Computer Program and Computer Program Product - The invention relates to a method for operating virtual networks. The method comprises providing a first virtual network ( | 01-01-2009 |
20090037583 | DETECTION AND CONTROL OF PEER-TO-PEER COMMUNICATION - A method and apparatus are provided for detecting peer-to-peer communication on a data communication network, between an internal client machine within an internal address space and an external client machine. The method includes routing all messages addressed to internal client machines to an analysis device. The analysis device identifies messages pertaining to peer-to-peer communication and identifies the internal client machine to which the messages of a specified nature were addressed. The analysis device terminates the connection with the external client machine if the establishing of the peer-to-peer communication is in violation of a pre-determined internal network rule. | 02-05-2009 |
20090144419 | IP NETWORK MANAGEMENT - Methods and apparatus are provided for managing an IP network interconnecting a plurality of network hosts ( | 06-04-2009 |
20090192780 | HARDWARE EMULATION USING ON-THE-FLY VIRTUALIZATION - At least one anomaly associated with at least one actual hardware element in a computer system having a plurality of hardware elements is addressed. The anomaly is detected, and, responsive to the detection, a virtualization layer is inserted between (i) an operating system of the computer system, and (ii) the plurality of hardware elements. Hardware emulation and/or selective hardware activation/deactivation are performed on the at least one actual hardware element by the virtualization layer. The insertion of the virtualization layer is accomplished in an on-the-fly manner. | 07-30-2009 |
20090315916 | ON-THE-FLY CREATION OF VIRTUAL PLACES IN VIRTUAL WORLDS - A specification of a set of objects associated with at least one virtual world is obtained. The objects are laid out in a three-dimensional virtual representation. An on-the-fly virtual place is created in the virtual world, based on the layout. The virtual place depicts the set of objects in the three-dimensional virtual representation and enables navigation and interaction therewith | 12-24-2009 |
20100017866 | SECURE USER INTERACTION USING VIRTUALIZATION - A first virtualization layer is inserted between (i) an operating system of a computer system, and (ii) at least first and second hardware devices of the computer system. Data is communicated between the first hardware device and the second hardware device, via the first virtualization layer, without exposing the data to the operating system. | 01-21-2010 |
Patent application number | Description | Published |
20110009749 | SYSTEM FOR DIAGNOSING MULTIPLE SCLEROSIS - A system for determining at least one index out of a blood reflux rate index and increased blood resistance index in cerebral veins in a patient including a detection source set (TCCS, ECD) for detecting: —i) a blood reflux in at least one of the deep cerebral veins, —ii) a blood reflux in at least one of the internal jugular and/or vertebral veins; —iii) a stenose in at least one of the internal jugular vein; —iv) a lack of Doppler detectable blood flow in at least one of the internal jugular and/or vertebral veins; and —v) a negative difference between the cross-sectional area of at least one of the internal jugular veins in the supine posture and in the erect posture of said patient. The system further includes a processing module (PC) operatively connected to the detection source set (TCCS, ECD) to sense the condition where at least two of indexes i) to v) are positive so that the processing module (PC) emits an advice signal in case said condition is sensed. | 01-13-2011 |
20110021986 | DILATION CATHETER - A catheter (10) for treating stenotic sites in the human body (e.g. in the azygos vein) includes an expandable portion (12) having, when expanded, an arched shape. The arched shape may extends over an angle (a) of at least 90° degrees, and preferably of between 90° and 120° degrees, with a radius (R) of less than 3 centimetres, and preferably between 2 and 3 centimetres. The expandable portion AZY (12) may include a flexible support member, and expandable members coupled to the support member to impart, when expanded, the desired arched shape to the flexible support member. Alternatively, the expandable portion (12) may includes an actuator member acting longitudinally of and sidewise to the expandable portion to impart thereto the desired arched shape. | 01-27-2011 |
20110152734 | DEVICE FOR PNEUMATIC TREATMENT OF AN INFERIOR LIMB HAVING PERIPHERAL ARTERIOPATHY PROBLEMS | 06-23-2011 |
20120191112 | EXPANDABLE CATHETER ASSEMBLY AND CORRESPONDING KIT - A catheter ( | 07-26-2012 |
20120191727 | SYSTEM FOR DETECTING EXTRA CRANIAL VENOUS FLOW ANOMALIES - A system for detecting extracranial flow anomalies in a patient, for example for the purposes of the diagnosis of multiple sclerosis comprises:—a detection source (TCCS, ECD) to detect venous hemodynamics parameters representative of extracranial venous flow in a patient and generate corresponding signals, and—a processing device (PC) to receive said signals from the detection source (TCCS, ECD), configured ( | 07-26-2012 |
20120225791 | ARRAY-BASED METHOD FOR DETECTION OF COPY NUMBER VARIATIONS IN THE HLA LOCUS FOR THE GENETIC DETERMINATION OF SUSCEPTIBILITY OF DEVELOPMENT OF VENOUS MALFORMATIONS IN THE EXTRACRANIAL SEGMENTS OF THE CEREBROSPINAL VEINS AND KIT THEREOF - Method for in vitro diagnosis of susceptiblility of developing venous malformations i the extracranial segment of the cerebrospinal veins in a patient comprising the detection of copy number variations (CNVs) in chromosome 6p21 in a sample of genomic DNA of the patient, wherein the venous malformations are associated with the development of multiple sclerosis. | 09-06-2012 |
Patent application number | Description | Published |
20090288638 | METHOD AND SYSTEM FOR CONTROLLING OPERATING PRESSURE IN A COMMON-RAIL FUEL INJECTION SYSTEM, PARTICULARLY FOR A DIESEL ENGINE - In a fuel injection system of an internal combustion engine that includes, but is not limited to injectors (I | 11-26-2009 |
20090299606 | METHOD AND SYSTEM FOR CONTROLLING A HIGH PRESSURE PUMP, PARTICULARLY FOR A DIESEL ENGINE FUEL INJECTION SYSTEM - In a fuel injection system of an internal combustion engine, including, but not limited to a high pressure pump adapted to deliver a fuel mass conveyed from a fuel tank to a high pressure region to which a plurality of injectors is connected, including a fuel metering device for adjusting the fuel quantity to be delivered to the high pressure region, a pressure sensor for measuring fuel pressure in the high pressure region; and an electronic control unit arranged for driving the fuel metering device through an energizing signal (Inom; Iact) as a function of the measured fuel pressure and the engine operating mode, where the electronic control unit is arranged for determining the energizing signal (Inom; Iact) for driving the fuel metering device according to a nominal characteristic curve (A) of the high pressure pump representative of a predetermined relationship between the energizing signal and the fuel mass delivered by the pump, the operating pressure is controlled by driving the fuel metering device with an energizing signal determined according to an updated characteristic curve (B) estimated by applying to the nominal characteristic curve (A) an offset between the actual energizing signal value (Iact) related to the controlled fuel mass delivered to the high pressure region in a predetermined engine operating point and a nominal energizing signal (Inom) related to the controlled fuel mass according to the nominal characteristic curve (A). | 12-03-2009 |
20120024263 | METHOD FOR ESTIMATING FUEL INJECTING PRESSURE - A method is provided for estimating fuel injecting pressure of an injector belonging to a fuel injection system of an internal combustion engine. The fuel injection system includes, but is not limited to a fuel rail and at least one injector that are fluidly connected with the fuel rail through a connecting conduit. The method includes, but is not limited to modelling the pressure fluctuation within the connecting conduit according to the equation P=B·e | 02-02-2012 |
Patent application number | Description | Published |
20090011020 | Gastroresistant Pharmaceutical Formulations Containing Rifaximin - The object of the invention consists of pharmaceutical formulations containing rifaximin in the shape of microgranules made gastroresistant by an insoluble polymer at pH values between 1.5 and 4.0 and soluble at pH values between 5.0 and 7.5, by their preparation and by their use in the manufacture of medicinal preparations useful in the treatment of inflammatory bowel diseases (IBD) and mainly Crohn's disease. | 01-08-2009 |
20100330129 | Gastroresistant Pharmaceutical Formulations Containing Rifaximin - The object of the invention consists of pharmaceutical formulations containing rifaximin in the shape of microgranules made gastroresistant by an insoluble polymer at pH values between 1.5 and 4.0 and soluble at pH values between 5.0 and 7.5, by their preparation and by their use in the manufacture of medicinal preparations useful in the treatment of inflammatory bowel diseases (IBD) and mainly Crohn's disease. | 12-30-2010 |
20140112987 | GASTRORESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN - The object of the invention consists of pharmaceutical formulations containing rifaximin in the shape of microgranules made gastroresistant by an insoluble polymer at pH values between 1.5 and 4.0 and soluble at pH values between 5.0 and 7.5, by their preparation and by their use in the manufacture of medicinal preparations useful in the treatment of inflammatory bowel diseases (IBD) and mainly Crohn's disease. | 04-24-2014 |
20140186450 | GASTRORESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN - The object of the invention consists of pharmaceutical formulations containing rifaximin in the shape of microgranules made gastroresistant by an insoluble polymer at pH values between 1.5 and 4.0 and soluble at pH values between 5.0 and 7.5, by their preparation and by their use in the manufacture of medicinal preparations useful in the treatment of inflammatory bowel diseases (IBD) and mainly Crohn's disease. | 07-03-2014 |